Key points are not available for this paper at this time.
INTRODUCTION: Many multi-genic systemic diseases such as neurological disorders, inflammatory diseases, and the majority of cancers do not have effective treatments yet. Reinforcement learning powered systems pharmacology is a potentially effective approach to designing personalized therapies for untreatable complex diseases. AREAS COVERED: In this survey, state-of-the-art reinforcement learning methods and their latest applications to drug design are reviewed. The challenges on harnessing reinforcement learning for systems pharmacology and personalized medicine are discussed. Potential solutions to overcome the challenges are proposed. EXPERT OPINION: drug design.
Building similarity graph...
Analyzing shared references across papers
Loading...
Expert Opinion on Drug Discovery
Cornell University
City University of New York
The Graduate Center, CUNY
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Tan et al. (Thu,) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: